- Home
- RFIL vs PMN Comparison
RFIL vs PMN Comparison
Compare RFIL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- PMN
- Stock Information
- Founded
- RFIL 1979
- PMN 2004
- Country
- RFIL United States
- PMN Canada
- Employees
- RFIL N/A
- PMN N/A
- Industry
- RFIL Electrical Products
- PMN Pharmaceuticals and Biotechnology
- Sector
- RFIL Technology
- PMN Health Care
- Exchange
- RFIL Nasdaq
- PMN Nasdaq
- Market Cap
- RFIL 39.9M
- PMN 33.7M
- IPO Year
- RFIL N/A
- PMN N/A
- Fundamental
- Price
- RFIL $4.15
- PMN $0.89
- Analyst Decision
- RFIL Strong Buy
- PMN
- Analyst Count
- RFIL 1
- PMN 0
- Target Price
- RFIL $4.50
- PMN N/A
- AVG Volume (30 Days)
- RFIL 21.1K
- PMN 53.0K
- Earning Date
- RFIL 01-16-2025
- PMN 11-14-2024
- Dividend Yield
- RFIL N/A
- PMN N/A
- EPS Growth
- RFIL N/A
- PMN N/A
- EPS
- RFIL N/A
- PMN N/A
- Revenue
- RFIL $64,857,000.00
- PMN N/A
- Revenue This Year
- RFIL N/A
- PMN N/A
- Revenue Next Year
- RFIL $8.38
- PMN N/A
- P/E Ratio
- RFIL N/A
- PMN N/A
- Revenue Growth
- RFIL N/A
- PMN N/A
- 52 Week Low
- RFIL $2.84
- PMN $0.87
- 52 Week High
- RFIL $4.65
- PMN $2.61
- Technical
- Relative Strength Index (RSI)
- RFIL 54.47
- PMN 40.96
- Support Level
- RFIL $3.80
- PMN $0.88
- Resistance Level
- RFIL $4.60
- PMN $0.96
- Average True Range (ATR)
- RFIL 0.21
- PMN 0.07
- MACD
- RFIL 0.06
- PMN -0.01
- Stochastic Oscillator
- RFIL 46.43
- PMN 4.04
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.